Kala Bio Q2 EPS $(21.32) Up From $(85.64) YoY, Sales $0.00, Same YoY

Benzinga Newsdesk www.benzinga.com Negative 74.6%

Neg 74.6% Neu 0% Pos 0%

Kala Bio (NASDAQ:KALA) reported quarterly losses of $(21.32) per share. This is a 75.11 percent increase over losses of $(85.64) per share from the same period last year. The company reported $0.00 in sales this quarter. This is the same as the same period last year.